Crossmark

Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors

Crossref DOI link: https://doi.org/10.1038/onc.2017.400

Published Online: 2017-10-23

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Araiza-Olivera, D

Feng, Y

Semenova, G

Prudnikova, T Y

Rhodes, J

Chernoff, J https://orcid.org/0000-0002-4803-7836
License Information

Text and Data Mining valid from 2017-10-23
More Information

Article History

Received: 1 May 2017

Revised: 28 July 2017

Accepted: 1 September 2017

First Online: 23 October 2017

Competing interests

: The authors declare no conflict of interest.